Curi RMB Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.9M | Buy |
46,597
+3,451
| +8% | +$1.87M | 0.41% | 64 |
|
|
2025
Q4 | $25M | Buy |
43,146
+14,251
| +49% | +$8.06M | 0.43% | 54 |
|
|
2025
Q3 | $14M | Buy |
28,895
+1,354
| +5% | +$630K | 0.26% | 105 |
|
|
2025
Q2 | $11.2M | Buy |
27,541
+14,342
| +109% | +$6M | 0.21% | 129 |
|
|
2025
Q1 | $6.57M | Sell |
13,199
-4,702
| -26% | -$2.55M | 0.16% | 167 |
|
|
2024
Q4 | $9.31M | Buy |
17,901
+418
| +2% | +$230K | 0.21% | 140 |
|
|
2024
Q3 | $10.8M | Buy |
17,483
+1,000
| +6% | +$592K | 0.25% | 123 |
|
|
2024
Q2 | $9.12M | Sell |
16,483
-2,579
| -14% | -$1.48M | 0.22% | 136 |
|
|
2024
Q1 | $11.1M | Buy |
19,062
+11,365
| +148% | +$6.38M | 0.25% | 119 |
|
|
2023
Q4 | $4.09M | Buy |
7,697
+420
| +6% | +$203K | 0.12% | 174 |
|
|
2023
Q3 | $3.68M | Buy |
7,277
+41
| +0.6% | +$21.8K | 0.13% | 167 |
|
|
2023
Q2 | $3.78M | Buy |
7,236
+374
| +5% | +$202K | 0.12% | 165 |
|
|
2023
Q1 | $3.95M | Buy |
6,862
+453
| +7% | +$255K | 0.14% | 152 |
|
|
2022
Q4 | $3.53M | Sell |
6,409
-19
| -0.3% | -$10.1K | 0.13% | 165 |
|
|
2022
Q3 | $3.26M | Buy |
6,428
+5,925
| +1,178% | +$3.32M | 0.12% | 171 |
|
|
2022
Q2 | $273K | Buy |
503
+21
| +4% | +$11.6K | 0.01% | 420 |
|
|
2022
Q1 | $285K | Hold |
482
| – | – | 0.01% | 393 |
|
|
2021
Q4 | $322K | Sell |
482
-106
| -18% | -$66.2K | 0.01% | 393 |
|
|
2021
Q3 | $336K | Buy |
588
+106
| +22% | +$58.2K | 0.01% | 381 |
|
|
2021
Q2 | $243K | Sell |
482
-519
| -52% | -$245K | 0.01% | 431 |
|
|
2021
Q1 | $457K | Sell |
1,001
-221
| -18% | -$105K | 0.02% | 363 |
|
|
2020
Q4 | $569K | Sell |
1,222
-695
| -36% | -$326K | 0.02% | 411 |
|
|
2020
Q3 | $846K | Sell |
1,917
-102
| -5% | -$42.1K | 0.04% | 326 |
|
|
2020
Q2 | $731K | Sell |
2,019
-95
| -4% | -$31.8K | 0.03% | 349 |
|
|
2020
Q1 | $600K | Sell |
2,114
-14
| -0.7% | -$4.42K | 0.03% | 370 |
|
|
2019
Q4 | $691K | Sell |
2,128
-10,632
| -83% | -$3.22M | 0.02% | 407 |
|
|
2019
Q3 | $3.72M | Buy |
12,760
+1,496
| +13% | +$428K | 0.1% | 208 |
|
|
2019
Q2 | $3.31M | Buy |
11,264
+872
| +8% | +$240K | 0.08% | 235 |
|
|
2019
Q1 | $2.85M | Buy |
10,392
+9,287
| +840% | +$2.31M | 0.07% | 279 |
|
|
2018
Q4 | $247K | Sell |
1,105
-52
| -4% | -$12.2K | 0.01% | 786 |
|
|
2018
Q3 | $282K | Buy |
1,157
+2
| +0.2% | +$460 | 0.01% | 744 |
|
|
2018
Q2 | $239K | Sell |
1,155
-4,153
| -78% | -$882K | 0.01% | 777 |
|
|
2018
Q1 | $1.1M | Sell |
5,308
-4,200
| -44% | -$882K | 0.03% | 493 |
|
|
2017
Q4 | $1.8M | Sell |
9,508
-49,147
| -84% | -$9.42M | 0.05% | 396 |
|
|
2017
Q3 | $11.1M | Sell |
58,655
-935
| -2% | -$169K | 0.29% | 105 |
|
|
2017
Q2 | $10.4M | Buy |
+59,590
| New | +$10M | 0.3% | 103 |
|
Other funds holding TMO
VCM
Curi RMB Capital's TMO Position: Q1 2026 in Review
Curi RMB Capital increased its Thermo Fisher Scientific (TMO) stake by 8% in Q1 2026, buying an estimated $1.87M and bringing the position to 46,597 shares worth $22.9M. The position accounts for 0.41% of the portfolio, ranked #64.
Curi RMB Capital first reported a position in TMO in Q2 2017 and has held it in 36 quarters since. The position peaked at $25M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Curi RMB Capital held 46,597 shares of Thermo Fisher Scientific worth $22.9M as of Q1 2026.
- Curi RMB Capital bought 3,451 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.87M.
- Thermo Fisher Scientific made up 0.41% of Curi RMB Capital's portfolio in Q1 2026, its #64 holding.
- Curi RMB Capital first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 36 quarters since.
- Curi RMB Capital's Thermo Fisher Scientific position peaked at $25M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.